Antagonistic effects of thiazolidinediones and cytokines in lipotoxicity

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 3, 2010, Pages 377-380

  Smith, Ulf ^a   Hammarstedt, Ann ^a  

^a Center for Cardiovascular and Metabolic Research   (Sweden)

Author keywords

Adipogenesis; Adipose tissue; Obesity; PPAR ; TNF

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; CYTOKINE; INSULIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOGENESIS; ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DRUG ANTAGONISM; HUMAN; INHIBITION KINETICS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID OXIDATION; LIPOHYPERTROPHY; LIPOTOXICITY; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROADIPOCYTE; REVIEW; SUBCUTANEOUS FAT;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CYTOKINES; HUMANS; LIPID METABOLISM; MICE; OBESITY; PPAR GAMMA; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76349086898     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.11.006     Document Type: Review

References (32)

1. Yang X., and Smith U. Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer?. Diabetologia 50 (2007) 1127-1139
2. Gustafson B., Hammarstedt A., Andersson C.X., and Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2276-2283
3. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003) 1796-1808
4. Murano I., Barbatelli G., Parisani V., Latini C., Muzzonigro G., Castellucci M., and Cinti S. Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J. Lipid Res. 49 (2008) 1562-1568
5. Guilherme A., Virbasius J.V., Puri V., and Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell. Biol. 9 (2008) 367-377
6. Isakson P., Hammarstedt A., Gustafson B., and Smith U. Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes 58 (2009) 1550-1557
7. Tchoukalova Y., Koutsari C., and Jensen M. Committed subcutaneous preadipocytes are reduced in human obesity. Diabetologia 50 (2007) 151-157
8. Krotkiewski M., Bjorntorp P., Sjostrom L., and Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J. Clin. Invest. 72 (1983) 1150-1162
9. Spalding K.L., Arner E., Westermark P.O., Bernard S., Buchholz B.A., Bergmann O., Blomqvist L., Hoffstedt J., Naslund E., Britton T., Concha H., Hassan M., Ryden M., Frisen J., and Arner P. Dynamics of fat cell turnover in humans. Nature 453 (2008) 783-787
10. Stefan N., Kantartzis K., Machann J., Schick F., Thamer C., Rittig K., Balletshofer B., Machicao F., Fritsche A., and Haring H.U. Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 168 (2008) 1609-1616
11. Marini M.A., Succurro E., Frontoni S., Hribal M.L., Andreozzi F., Lauro R., Perticone F., and Sesti G. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care 30 (2007) 2145-2147
12. Medina-Gomez G., Gray S.L., Yetukuri L., Shimomura K., Virtue S., Campbell M., Curtis R.K., Jimenez-Linan M., Blount M., Yeo G.S., Lopez M., Seppanen-Laakso T., Ashcroft F.M., Oresic M., and Vidal-Puig A. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet. 3 (2007) e64
13. Londos C., Sztalryd C., Tansey J.T., and Kimmel A.R. Role of PAT proteins in lipid metabolism. Biochimie 87 (2005) 45-49
14. Ruderman N., Chisholm D., Pi-Sunyer X., and Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 47 (1998) 699-713
15. Rosen E.D., and MacDougald O.A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell. Biol. 7 (2006) 885-896
16. Tesz G.J., Guilherme A., Guntur K.V., Hubbard A.C., Tang X., Chawla A., and Czech M.P. Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2. J. Biol. Chem. 282 (2007) 19302-19312
17. Gustafson B., and Smith U. Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J. Biol. Chem. 281 (2006) 9507-9516
18. Cawthorn W.P., Heyd F., Hegyi K., and Sethi J.K. Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4(TCF7L2)-dependent pathway. Cell Death Differ. 14 (2007) 1361-1373
19. Charriere G., Cousin B., Arnaud E., Andre M., Bacou F., Penicaud L., and Casteilla L. Preadipocyte conversion to macrophage. Evidence of plasticity. J. Biol. Chem. 278 (2003) 9850-9855
20. Hammarstedt A., Isakson P., Gustafson B., and Smith U. Wnt-signaling is maintained and adipogenesis inhibited by TNFalpha but not MCP-1 and resistin. Biochem. Biophys. Res. Commun. 357 (2007) 700-706
21. Rosen E.D., and Spiegelman B.M. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276 (2001) 37731-37734
22. Fried S.K., Bunkin D.A., and Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83 (1998) 847-850
23. Fain J.N., Madan A.K., Hiler M.L., Cheema P., and Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145 (2004) 2273-2282
24. Sewter C.P., Blows F., Vidal-Puig A., and O'Rahilly S. Regional differences in the response of human pre-adipocytes to PPARgamma and RXRalpha agonists. Diabetes 51 (2002) 718-723
25. Unger R.H. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144 (2003) 5159-5165
26. Belfort R., Harrison S.A., Brown K., Darland C., Finch J., Hardies J., Balas B., Gastaldelli A., Tio F., Pulcini J., Berria R., Ma J.Z., Dwivedi S., Havranek R., Fincke C., DeFronzo R., Bannayan G.A., Schenker S., and Cusi K. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 355 (2006) 2297-2307
27. Hammarstedt A., Sopasakis V.R., Gogg S., Jansson P.A., and Smith U. Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects. Diabetologia 48 (2005) 96-104
28. Nawrocki A.R., Rajala M.W., Tomas E., Pajvani U.B., Saha A.K., Trumbauer M.E., Pang Z., Chen A.S., Ruderman N.B., Chen H., Rossetti L., and Scherer P.E. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 281 (2006) 2654-2660
29. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., and Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8 (2002) 1288-1295
30. Okuno A., Tamemoto H., Tobe K., Ueki K., Mori Y., Iwamoto K., Umesono K., Akanuma Y., Fujiwara T., Horikoshi H., Yazaki Y., and Kadowaki T. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 101 (1998) 1354-1361
31. de Souza C.J., Eckhardt M., Gagen K., Dong M., Chen W., Laurent D., and Burkey B.F. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 50 (2001) 1863-1871
32. Wang M.Y., Grayburn P., Chen S., Ravazzola M., Orci L., and Unger R.H. Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 6139-6144